Biocon completes 10% stake sale in Syngene
Biotechnology major Biocon on Monday concluded sale of 10 percent stake in its research arm Syngene for Rs 380 crore to IVF Trustee Company Private Ltd.
Jan 12, 2015, 19:26 PM IST
Biotechnology major Biocon on Monday concluded sale of 10 percent stake in its research arm Syngene for Rs 380 crore to IVF Trustee Company Private Ltd.
Jan 12, 2015, 19:26 PM IST